Prevention of sudden death in patients with heart failure: Cardiac resynchronization therapy with or without back-up defibrillation;Prevenzione della morte improvvisa nel paziente con insufficienza cardiaca: terapia di resincronizzazione cardiaca con o senza back-up di defibrillazione

Giornale Italiano di Cardiologia

Volumn 11, Issue 10 SUPPL.1, 2010, Pages

  Pedretti, Roberto F E ^a   Laporta, Antonio ^a   Masnaghetti, Sergio ^a   Raimondo, Rosa ^a   Salerno, Mario ^a   Santoro, Francesco ^a   Vaninetti, Raffaella ^a  

^a IRCCS   (Italy)

Author keywords

Cardiac resynchronization therapy; Heart failure; Implantable defibrillators; Sudden death

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COMPARATIVE STUDY; DEFIBRILLATOR; ECONOMICS; FORCED EXPIRATORY VOLUME; HEART FAILURE; HUMAN; MORTALITY; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; SUDDEN DEATH;

CARDIAC RESYNCHRONIZATION THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FORCED EXPIRATORY VOLUME; GUIDELINES AS TOPIC; HEART FAILURE; HUMANS; PROGNOSIS; QUALITY OF LIFE;

EID: 79955704592     PISSN: 18276806     EISSN: 19726481     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-40.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-90.
3. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
4. Kadish A, Dyer A, Daubert JP, et al Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-8.
5. Bardy GH, Lee KL, Mark DB, et al Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
6. McAlister FA, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 2007; 297: 2502-14.
7. Bristow MR, Saxon LA, Boehmer J, et al Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.
8. Cleland JG, Daubert JC, Erdmann E, et al; Cardiac Resynchronization- Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.
9. Cleland JG, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CAREHF) trial extension phase]. Eur Heart J 2006; 27: 1928-32.
10. Goldenberg I, Vyas AK, Hall WJ, et al MADIT-II Investigators. Risk stratification for primary implantation of a cardioverterdefibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008; 51: 288-96.
11. Jessup M, Abraham WT, Casey DE, et al. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
12. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006; 113: 1424-33.
13. Levy WC, Lee KL, Hellkamp AS, et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation 2009; 120: 835-42.
14. Moss AJ, Hall WJ, Cannom DS, et al MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-38.